Ibogaine has shown promise as a treatment for opioid addiction.
The Bluegrass State is looking to become the first in the U.S. to trial ibogaine as a potential treatment for opioid addiction, Forbes reported.
The Kentucky Opioid Abatement Advisory Commission is considering the allocation of $42 million from a settlement with opioid producers to finance ibogaine trials.
Ibogaine is derived from the root of a West African shrub and has shown promise as a treatment for opioid addiction.
Read the full story on the Forbes website.